Top in GI: Telehealth, IBD treatment selection

Both patients and gastroenterologists have reported being highly satisfied with telehealth services amid COVID-19, according to results from a recent study. It was the top story in gastroenterology last week.

Another top story was about the challenge of selecting the initial treatment for patients newly diagnosed with inflammatory bowel disease (IBD).

Read these and more top stories in gastroenterology below:

GIs, patients highly satisfied with telehealth during COVID-19

Both patients and gastroenterologists have been highly satisfied with telehealth services during the COVID-19 pandemic, according results from a survey published in Clinical Gastroenterology and Hepatology. Read more.

Smarter, earlier, deeper: Choosing an initial IBD therapy

There are many different treatments for IBD and choosing the right one for a patient with a new diagnosis can be a challenge. In a virtual presentation for the Interdisciplinary Autoimmune Summit, Adam Cheifetz, MD, director of the IBD center at Beth Israel Deaconess Medical Center, said to optimize therapy, physicians need to think about treating smarter, earlier, deeper, to a targeted goal and more effectively. Read more.

Entyvio linked with lower risk for non-infectious adverse events in Crohn’s

Entyvio (vedolizumab, Takeda) yielded a lower risk for non-infectious serious adverse events than TNF antagonist therapy in Crohn’s disease, according to a study published in Alimentary Pharmacology and Therapeutics. Read more.

Emerging therapies for IBD: Finding long-term treatment without steroids

There are currently many new and emerging therapies for IBD. During a recent presentation, Stephen B. Hanauer, MD, professor of medicine at Northwestern University in Chicago, said gastroenterologists need to begin to use biologic agents that are more highly effective overall. Read more.

ASGE to hold virtual, interactive endoscopy postgraduate course

The American Society for Gastrointestinal Endoscopy has rescheduled their Endoscopy 2020 Postgraduate Course to be held virtually on July 18, 2020. Read more.